Janone Inc. (NASDAQ:ALTS) Sees Significant Decrease in Short Interest

Janone Inc. (NASDAQ:ALTS) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 147,900 shares, a decline of 39.3% from the October 15th total of 243,600 shares. Based on an average daily volume of 306,200 shares, the short-interest ratio is presently 0.5 days. Approximately 1.1% of the company’s stock are sold short.

Janone Trading Up 5.6 %

NASDAQ ALTS opened at $2.45 on Thursday. The business has a fifty day moving average price of $2.16. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. Janone has a 1 year low of $0.30 and a 1 year high of $5.26.

About Janone

JanOne Inc, a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology.